proline and Porphyria Cutanea Tarda

proline has been researched along with Porphyria Cutanea Tarda in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chaparro, M; García-Buey, L; Rojo, E1
Aguilera, P; Laguno, M; To-Figueras, J1

Other Studies

2 other study(ies) available for proline and Porphyria Cutanea Tarda

ArticleYear
Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease.
    Journal of Crohn's & colitis, 2020, May-21, Volume: 14, Issue:4

    Topics: Aminoisobutyric Acids; Antibodies, Monoclonal, Humanized; Benzimidazoles; Crohn Disease; Cyclopropanes; Gastrointestinal Agents; Hepatitis C; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Porphyria Cutanea Tarda; Proline; Pyrrolidines; Quinoxalines; Sulfonamides

2020
Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda.
    The British journal of dermatology, 2014, Volume: 171, Issue:6

    Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Porphyria Cutanea Tarda; Proline; Remission Induction

2014